[Psychiatric and cognitive long-term effects of ecstasy]
- PMID: 16505868
[Psychiatric and cognitive long-term effects of ecstasy]
Abstract
Background: MDMA (ecstasy) has been a popular recreational drug among young people. MDMA modulates serotonergic activity in the brain and has been shown to be toxic to serotonergic neurons in animals. Disturbances in this neurotransmitter system lead to neuropsychiatric symptoms, hence it has been a concern that use of ecstasy in humans would lead to a higher frequency of psychiatric disease and cognitive impairment. We wanted to review human studies to find evidence for these side effects of ecstasy.
Materials and methods: We investigated 10 studies regarding the connection between use of ecstasy and mental health, as well as 20 studies regarding the connection between use of ecstasy and cognitive impairment. Three of these studies were longitudinal, the others were cross-sectional.
Results and interpretation: There is a higher frequency of both psychiatric illness and cognitive impairment among ecstasy users. On the other hand, many methodological factors must be considered before causality is assumed.
Similar articles
-
Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?Addiction. 2006 Mar;101(3):348-61. doi: 10.1111/j.1360-0443.2006.01314.x. Addiction. 2006. PMID: 16499508 Review.
-
Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.J Psychopharmacol. 2006 Mar;20(2):211-25. doi: 10.1177/0269881106059486. J Psychopharmacol. 2006. PMID: 16510479 Review.
-
Long-term neuropsychiatric consequences of "ecstasy" (MDMA): a review.Harv Rev Psychiatry. 2002 Jul-Aug;10(4):212-20. Harv Rev Psychiatry. 2002. PMID: 12119307 Review.
-
The dark side of ecstasy: neuropsychiatric symptoms after exposure to 3,4-methylenedioxymethamphetamine.Basic Clin Pharmacol Toxicol. 2008 Jan;102(1):15-24. doi: 10.1111/j.1742-7843.2007.00159.x. Epub 2007 Nov 28. Basic Clin Pharmacol Toxicol. 2008. PMID: 18047478 Review.
-
The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview.J Psychopharmacol. 2006 Mar;20(2):188-93. doi: 10.1177/0269881106059939. J Psychopharmacol. 2006. PMID: 16510477 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical